These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
542 related articles for article (PubMed ID: 9572491)
21. Preferential overexpression of a 172Arg-->Leu mutant p53 in the mammary gland of transgenic mice results in altered lobuloalveolar development. Li B; Greenberg N; Stephens LC; Meyn R; Medina D; Rosen JM Cell Growth Differ; 1994 Jul; 5(7):711-21. PubMed ID: 7947386 [TBL] [Abstract][Full Text] [Related]
22. Understanding mammary gland development through the imbalanced expression of growth regulators. Robinson GW; Smith GH; Gallahan D; Zimmer A; Furth PA; Hennighausen L Dev Dyn; 1996 Jun; 206(2):159-68. PubMed ID: 8725283 [TBL] [Abstract][Full Text] [Related]
23. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418 [TBL] [Abstract][Full Text] [Related]
24. Overexpression of Bcl-2 inhibits alveolar cell apoptosis during involution and accelerates c-myc-induced tumorigenesis of the mammary gland in transgenic mice. Jäger R; Herzer U; Schenkel J; Weiher H Oncogene; 1997 Oct; 15(15):1787-95. PubMed ID: 9362445 [TBL] [Abstract][Full Text] [Related]
25. Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage. Shibata MA; Liu ML; Knudson MC; Shibata E; Yoshidome K; Bandey T; Korsmeyer SJ; Green JE EMBO J; 1999 May; 18(10):2692-701. PubMed ID: 10329616 [TBL] [Abstract][Full Text] [Related]
26. p53 mediates a default programme of mammary gland involution in the absence of STAT3. Matthews JR; Clarke AR Oncogene; 2005 Apr; 24(19):3083-90. PubMed ID: 15735683 [TBL] [Abstract][Full Text] [Related]
27. Functional abrogation of p53 is required for T-Ag induced proliferation in cardiomyocytes. Huh NE; Pasumarthi KB; Soonpaa MH; Jing S; Patton B; Field LJ J Mol Cell Cardiol; 2001 Aug; 33(8):1405-19. PubMed ID: 11448130 [TBL] [Abstract][Full Text] [Related]
28. The MMTV/c-myc transgene and p53 null alleles collaborate to induce T-cell lymphomas, but not mammary carcinomas in transgenic mice. Elson A; Deng C; Campos-Torres J; Donehower LA; Leder P Oncogene; 1995 Jul; 11(1):181-90. PubMed ID: 7624126 [TBL] [Abstract][Full Text] [Related]
30. Perturbation of beta1-integrin function alters the development of murine mammary gland. Faraldo MM; Deugnier MA; Lukashev M; Thiery JP; Glukhova MA EMBO J; 1998 Apr; 17(8):2139-47. PubMed ID: 9545227 [TBL] [Abstract][Full Text] [Related]
31. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis. Iavnilovitch E; Groner B; Barash I Mol Cancer Res; 2002 Nov; 1(1):32-47. PubMed ID: 12496367 [TBL] [Abstract][Full Text] [Related]
32. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus. Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997 [TBL] [Abstract][Full Text] [Related]
33. Enhanced expression of vascular endothelial growth factor (VEGF) plays a critical role in the tumor progression potential induced by simian virus 40 large T antigen. Catalano A; Romano M; Martinotti S; Procopio A Oncogene; 2002 Apr; 21(18):2896-900. PubMed ID: 11973650 [TBL] [Abstract][Full Text] [Related]
34. Pituitary neoplasia induced by expression of human neurotropic polyomavirus, JCV, early genome in transgenic mice. Gordon J; Del Valle L; Otte J; Khalili K Oncogene; 2000 Oct; 19(42):4840-6. PubMed ID: 11039901 [TBL] [Abstract][Full Text] [Related]
35. Overexpression of human Cripto-1 in transgenic mice delays mammary gland development and differentiation and induces mammary tumorigenesis. Sun Y; Strizzi L; Raafat A; Hirota M; Bianco C; Feigenbaum L; Kenney N; Wechselberger C; Callahan R; Salomon DS Am J Pathol; 2005 Aug; 167(2):585-97. PubMed ID: 16049342 [TBL] [Abstract][Full Text] [Related]
36. H-ras induced transformation of mammary epithelium is favoured by increased oncogene expression or by inhibition of mammary regression. Andres AC; Bchini O; Schubaur B; Dolder B; LeMeur M; Gerlinger P Oncogene; 1991 May; 6(5):771-9. PubMed ID: 2052356 [TBL] [Abstract][Full Text] [Related]
37. Reduced circulating insulin-like growth factor I levels delay the onset of chemically and genetically induced mammary tumors. Wu Y; Cui K; Miyoshi K; Hennighausen L; Green JE; Setser J; LeRoith D; Yakar S Cancer Res; 2003 Aug; 63(15):4384-8. PubMed ID: 12907608 [TBL] [Abstract][Full Text] [Related]
38. Inhibition of SV40 large T antigen induced apoptosis by small T antigen. Kolzau T; Hansen RS; Zahra D; Reddel RR; Braithwaite AW Oncogene; 1999 Sep; 18(40):5598-603. PubMed ID: 10523837 [TBL] [Abstract][Full Text] [Related]
39. The influence of SV40 immortalization of human fibroblasts on p53-dependent radiation responses. Kohli M; Jorgensen TJ Biochem Biophys Res Commun; 1999 Apr; 257(1):168-76. PubMed ID: 10092528 [TBL] [Abstract][Full Text] [Related]
40. Effect of conditional knockout of the type II TGF-beta receptor gene in mammary epithelia on mammary gland development and polyomavirus middle T antigen induced tumor formation and metastasis. Forrester E; Chytil A; Bierie B; Aakre M; Gorska AE; Sharif-Afshar AR; Muller WJ; Moses HL Cancer Res; 2005 Mar; 65(6):2296-302. PubMed ID: 15781643 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]